<DOC>
	<DOCNO>NCT00609310</DOCNO>
	<brief_summary>Prove hypothesis dietary supplementation bioflavonoids diminish recurrence rate colonic neoplasia , implement clinical trial compare bioflavonoids placebo double blind randomize clinical trial . To use standardised supplementation bioflavonoids , commercially available preparation ( Flavo-NatinÂ® ) use .</brief_summary>
	<brief_title>Dietary Bioflavonoid Supplementation Prevention Neoplasia Recurrence</brief_title>
	<detailed_description>The preparation contain mixture 200mg chamomile tea ( green tea ) extract contain naturally occur bioflavonoids ( 2 % ) together vitamins folic acid . This flavonoids mixture apply 3 year compliance effect treatment determine measure serum concentration apigenin EGCG patient .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patient recent surgical resection colorectal cancer pathologically proven stage 2 stage 3 ( without adjuvant chemotherapy completion adjuvant chemotherapy ) accord UICC . The time interval recruitment within 312 month surgery . Male female caucasian 50 75 year old Brocaindex : 20 +25 % willing capable confirm write consent enrolment ample information provide stable condition expect change relevant medical condition occur study subject major relevant clinical abnormality ( base extensive medical history , physical examination , vital sign ) subject active cancer subject major clinically relevant laboratory abnormality . subject participate another trial investigational substance within last 4 week subject know suspected ( social ) drug dependent , incl . drink moderately willing abstain alcohol abuse active study phase subject adhere extreme diet lifestyle might interfere investigation subject know suspect comply study directives and/or know suspect reliable trustworthy subject know suspect capable understanding evaluate information give part formal information policy ( informed consent ) , particular regard risk discomfort would agree expose</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>clinical trial</keyword>
	<keyword>flavonoid treatment</keyword>
	<keyword>neoplasia recurrence</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>polypectomy</keyword>
	<keyword>adenoma Colon</keyword>
	<keyword>Neoplasia Recurrence Rates</keyword>
	<keyword>postpolypectomy patient</keyword>
</DOC>